|
1
|
Deepa M, Farooq S, Datta M, Deepa R and
Mohan V: Prevalence of metabolic syndrome using WHO, ATPIII and IDF
definitions in Asian Indians: The chennai urban rural epidemiology
study (CURES-34). Diabetes Metab Res Rev. 23:127–134.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Gaziano JM, Buring JE, Breslow JL,
Goldhaber SZ, Rosner B, VanDenburgh M, Willett W and Hennekens CH:
Moderate alcohol intake, increased levels of high-density
lipoprotein and its subfractions, and decreased risk of myocardial
infarction. N Engl J Med. 329:1829–1834. 1993.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Conigrave KM, Hu BF, Camargo CA Jr,
Stampfer MJ, Willett WC and Rimm EB: A prospective study of
drinking patterns in relation to risk of type 2 diabetes among men.
Diabetes. 50:2390–2395. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mukamal KJ, Conigrave KM, Mittleman MA,
Camargo CA Jr, Stampfer MJ, Willett WC and Rimm EB: Roles of
drinking pattern and type of alcohol consumed in coronary heart
disease in men. N Engl J Med. 348:109–118. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tolstrup J, Jensen MK, Tjonnald A, Overvad
K, Mukamal KJ and Grønbaek M: Prospective study of alcohol drinking
patterns and coronary heart diseases in women and men. BMJ.
332:1244–1248. 2006. View Article : Google Scholar
|
|
6
|
Gaziano JM, Gaziano TA, Glynn RJ, Sesso
HD, Ajani UA, Stampfer MJ, Manson JE, Hennekens CH and Buring JE:
Light-to-moderate alcohol consumption and mortality in the
Physicians' Health Study enrollment cohort. J Am Coll Cardiol.
35:96–105. 2000.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Freiberg MS, Cabral HJ, Heeren TC, Vasan
RS and Curtis Ellison R: Third National Health and Nutrition
Examination Survey: Alcohol consumption and the prevalence of the
metabolic syndrome in the US: A cross-sectional analysis of data
from the Third National Health And Nutrition Examination Survey.
Diabetes Care. 27:2954–2959. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Thun MJ, Peto R, Lopez AD, Monaco JH,
Henley SJ, Heath CW Jr and Doll R: Alcohol consumption and
mortality among middle-aged and elderly U.S. adults. N Engl J Med.
337:1705–1714. 1997.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wannamethee SG, Camargo CA Jr, Manson JE,
Willett WC and Rimm EB: Alcohol drinking patterns and risk of type
2 diabetes mellitus among younger women. Arch Intern Med.
163:1329–1336. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Neuschwander-Tetri BA: Nonalcoholic
steatohepatitis and the metabolic syndrome. Am J Med Sci.
330:326–335. 2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Marchesini G, Brizi M, Bianchi G,
Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S,
Forlani G and Melchionda N: Nonalcoholic fatty liver disease: A
feature of the metabolic syndrome. Diabetes. 50:1844–1850.
2001.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Eckel RH, Grundy SM and Zimmet PZ: The
metabolic syndrome. Lancet. 365:1415–1428. 2005.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N,
Fujimoto K, Chayama K and Saibara T: JSG-NAFLD: Prevalence and
associated metabolic factors of nonalcoholic fatty liver disease in
the general population from 2009 to 2010 in Japan: A multicenter
large retrospective study. J Gastroenterol. 47:586–595.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Nishioji K, Sumida Y, Kamaguchi M,
Mochizuki N, Kobayashi M, Nishimura T, Yamaguchi K and Itoh Y:
Prevalence of and risk factors for non-alcoholic fatty liver
diseases in a non-obese Japanese population, 2011-2012. J
Gastroenterol. 50:95–108. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Dunn W, Xu R and Schwimmer JB: Modest wine
drinking and decreased prevalence of suspected nonalcoholic fatty
liver disease. Hepatology. 47:1947–1954. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gunji T, Matsuhashi N, Sato H, Fujibayashi
K, Okumura M, Sasabe N and Urabe A: Light and moderate alcohol
consumption significantly reduces the prevalence of fatty liver in
the Japanese male population. Am J Gastroenterol. 104:2189–2195.
2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Moriya A, Iwasaki Y, Ohguchi S, Kayashima
E, Mitsumune T, Taniguchi H, Ikeda F, Shiratori Y and Yamamoto K:
Alcohol consumption appears to protect against non-alcoholic fatty
liver disease. Aliment Pharmacol Ther. 33:378–388. 2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hamaguchi M, Kojima T, Ohbora A, Takeda N,
Fukui M and Kato T: Protective effect of alcohol consumption for
fatty liver but not metabolic syndrome. World J Gastroenterol.
18:156–167. 2012.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sogabe M, Okahisa T, Taniguchi T, Tomonari
T, Tanaka T, Tanaka H, Nakasono M and Takayama T: Light alcohol
consumption plays a protective role against non-alcoholic fatty
liver disease in Japanese men with metabolic syndrome. Liver Int.
35:1707–1714. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kang HT, Kim JK, Shim JY, Lee HR, Linton
JA and Lee YJ: Low grade inflammation, metabolic syndrome and the
risk of chronic kidney disease: The 2005 Korean national health and
nutrition examination survey. J Korean Med Sci. 27:630–635.
2012.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yamagata K, Ishida K, Sairenchi T,
Takahashi H, Ohba S, Shiigai T, Narita M and Koyama A: Risk factors
for chronic kidney disease in a community-based population: A
10-year follow-up study. Kidney Int. 71:159–166. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shankar A, Klein R and Klein BE: The
association among smoking, heavy drinking, and chronic kidney
disease. Am J Epidemiol. 164:263–271. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jalal DI, Chonchol M, Chen W and Targher
G: Uric acid as a target of therapy in CKD. Am J Kidney Dis.
61:134–146. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Kodama S, Saito K, Yachi Y, Asumi M,
Sugawara A, Totsuka K, Saito A and Sone H: Association between
serum uric acid and development of type 2 diabetes. Diabetes Care.
32:1737–1742. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Feig DI, Kang DH and Johnson RJ: Uric acid
and cardiovascular risk. N Engl J Med. 359:1811–1821.
2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nakamura K, Sakurai M, Miura K, Morikawa
Y, Yoshita K, Ishizaki M, Kido T, Naruse Y, Suwazono Y and Nakagawa
H: Alcohol intake and the risk of hyperuricemia: A 6-year
prospective study in Japanese men. Nutr Metab Cardiovasc Dis.
22:989–996. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li Z, Guo X, Liu Y, Chang Y, Sun Y, Zhu G
and Abraham MR: The relation of moderate alcohol consumption to
hyperuricemia in a rural general population. Int J Environ Res
Public Health. 13(E732)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nakamura K, Okamura T, Hayakawa T, Hozawa
A, Kadowaki T, Murakami Y, Kita Y, Okayama A and Ueshima H: NIPPON
DATA90 Research Group: The proportion of individuals with
alcohol-induced hypertension among total hypertensives in a general
Japanese population: NIPPON DATA90. Hypertens Res. 30:663–668.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Okubo Y, Sairenchi T, Irie F, Yamagishi K,
Iso H, Watanabe H, Muto T, Tanaka K and Ota H: Association of
alcohol consumption with incident hypertension among middle-aged
and older Japanese population: The Ibaraki Prefectural Hearth Study
(IPHS). Hypertension. 63:41–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Oda N, Kajikawa M, Maruhashi T, Iwamoto Y,
Kishimoto S, Matsui S, Hidaka T, Kihara Y, Chayama K, Goto C, et
al: Endothelial function is impaired in relation to alcohol intake
even in the case of light alcohol consumption in Asian men:
Flow-mediated Dilation Japan (FMD-J) Study. Int J Cardiol.
230:523–528. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Research Committee for the Mega Database
of Japan Society of Ningen Dock, May 2019 : Nationwide data
analysis of the Ningen Dock in 2016 (Part 1) (In Japanese).
https://www.ningen-dock.jp/wp/wp-content/uploads/2013/09/2016dockdata-No1.pdf.
Accessed May 31, 2019.
|
|
32
|
Matsuzawa Y: Metabolic syndrome-definition
and diagnostic criteria in Japan. J Atheroscler Thromb.
12(301)2005.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hamaguchi M, Kojima T, Itoh Y, Harano Y,
Fujii K, Nakajima T, Kato T, Takeda N, Okuda J, Ida K, et al: The
severity of ultrasonographic findings in nonalcoholic fatty liver
disease reflects the metabolic syndrome and visceral fat
accumulation. Am J Gastroenterol. 102:2708–2715. 2007.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Examination Committee of Criteria for
‘Obesity Disease’ in Japan; Japan Society for the Study of Obesity:
New criteria for ‘obesity disease’ in Japan. Circ J 66: 987-992,
2002.
|
|
35
|
Levey AS, Coresh J, Balk E, Kausz AT,
Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J and Eknoyan G:
National Kidney Foundation: National Kidney Foundation practice
guidelines for chronic kidney disease: Evaluation, classification,
and stratification. Ann Intern Med. 139:137–147. 2003.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kiechl S, Willeit J, Poewe W, Egger G,
Oberhollenzer F, Muggeo M and Bonora E: Insulin sensitivity and
regular alcohol consumption: Large, prospective, cross sectional
population study (Bruneck study). BMJ. 313:1040–1044.
1996.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Sierksma A, Patel H, Ouchi N, Kihara S,
Funahashi T, Heine RJ, Grobbee DE, Kluft C and Hendriks HF: Effect
of moderate alcohol consumption on adiponectin, tumor necrosis
factor-alpha, and insulin sensitivity. Diabetes Care. 27:184–189.
2004.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Pischon T, Girman CJ, Rifai N,
Hotamisligil GS and Rimm EB: Association between dietary factors
and plasma adiponectin concentration in men. Am J Clin Nutr.
81:780–786. 2005.PubMed/NCBI View Article : Google Scholar
|
|
39
|
You M, Considine RV, Leone TC, Kelly DP
and Crabb DW: Role of adiponectin in the protective action of
dietary saturated fat against alcoholic fatty liver in mice.
Hepatology. 42:568–577. 2005.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rimm EB, Giovannucci EL, Willett WC,
Colditz GA, Ascherio A, Rosner B and Stampfer MJ: Prospective study
of alcohol consumption and risk of coronary disease in men. Lancet.
338:464–468. 1991.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rimm EB, Williams P, Fosher K, Criqui M
and Stampfer MJ: Moderate alcohol intake and lower risk of coronary
heart disease: Meta-analysis of effects on lipids and haemostatic
factors. BMJ. 319:1523–1528. 1999.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Mukamal KJ, Ding EL and Djoussé L: Alcohol
consumption, physical activity, and chronic disease risk factors: A
population-based cross-sectional survey. BMC Public Health.
6(118)2006.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fillmore KM, Golding JM, Graves KL, Kniep
S, Leino EV, Romelsjö A, Shoemaker C, Ager CR, Allebeck P and
Ferrer HP: Alcohol consumption and mortality. I. Characteristics of
drinking groups. Addiction. 93:183–203. 1998.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Goude D, Fagerberg B and Hulthe J: AIR
Study Group: Alcohol consumption, the metabolic syndrome and
insulin resistance in 58-year-old clinically healthy men (AIR
study). Clin Sci (Lond). 102:345–352. 2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Yoon YS, Oh SW, Baik HW, Park HS and Kim
WY: Alcohol consumption and the metabolic syndrome in Korean
adults: The 1998 Korean National Health and Nutrition Examination
Survey. Am J Clin Nutr. 80:217–224. 2004.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Rehm J, Mathers C, Popova S,
Thavorncharoensap M, Teerawattananon Y and Patra J: Global burden
of disease and injury and economic cost attribute to alcohol use
and alcohol-use disorders. Lancet. 373:2223–2233. 2009.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Kawano Y: Physio-pathological effects of
alcohol on the cardiovascular system: Its role in hypertension and
cardiovascular disease. Hypertens Res. 33:181–191. 2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
VanWagner LB, Ning H, Allen NB, Ajmera V,
Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA and Siddique J:
Alcohol use and cardiovascular disease risk in patients with
nonalcoholic fatty liver disease. Gastroenterology. 153:1260–1272.
2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yeboah J, McClelland RL, Polonsky TS,
Burke GL, Sibley CT, O'Leary D, Carr JJ, Goff DC, Greenland P and
Herrington DM: Comparison of novel risk markers for improvement in
cardiovascular risk assessment in intermediate-risk individuals.
JAMA. 308:788–795. 2012.PubMed/NCBI View Article : Google Scholar
|
